Public Employees Retirement System of Ohio Takes Position in Bruker Corporation $BRKR

Public Employees Retirement System of Ohio acquired a new position in Bruker Corporation (NASDAQ:BRKR) during the second quarter, HoldingsChannel.com reports. The fund acquired 33,220 shares of the medical research company’s stock, valued at approximately $1,999,000.

A number of other hedge funds have also added to or reduced their stakes in the business. Los Angeles Capital Management LLC acquired a new stake in Bruker in the 4th quarter valued at $26,000. Allworth Financial LP boosted its stake in shares of Bruker by 40.6% during the 3rd quarter. Allworth Financial LP now owns 890 shares of the medical research company’s stock worth $29,000 after buying an additional 257 shares during the last quarter. Essential Partners LLC bought a new position in shares of Bruker in the 1st quarter valued at about $36,000. Global Retirement Partners LLC acquired a new stake in shares of Bruker in the second quarter valued at about $38,000. Finally, Parallel Advisors LLC increased its position in shares of Bruker by 121.0% in the fourth quarter. Parallel Advisors LLC now owns 875 shares of the medical research company’s stock valued at $41,000 after acquiring an additional 479 shares during the last quarter. Institutional investors own 79.52% of the company’s stock.

Bruker Stock Performance

Shares of NASDAQ:BRKR opened at $58.50 on Monday. Bruker Corporation has a 52-week low of $29.84 and a 52-week high of $65.30. The company has a debt-to-equity ratio of 0.76, a quick ratio of 0.92 and a current ratio of 1.85. The company has a market capitalization of $8.91 billion, a P/E ratio of -83.57, a price-to-earnings-growth ratio of 1.79 and a beta of 1.26. The company has a 50-day simple moving average of $58.76 and a 200 day simple moving average of $48.73.

Bruker (NASDAQ:BRKR) last announced its quarterly earnings results on Tuesday, August 4th. The medical research company reported $0.49 earnings per share for the quarter, topping analysts’ consensus estimates of $0.38 by $0.11. The firm had revenue of $838.50 million for the quarter, compared to the consensus estimate of $853.57 million. Bruker had a positive return on equity of 12.47% and a negative net margin of 2.35%.The business’s revenue was up 5.2% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.32 earnings per share. Bruker has set its FY 2026 guidance at 2.100-2.150 EPS. Sell-side analysts forecast that Bruker Corporation will post 2.12 earnings per share for the current year.

Bruker Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, October 7th. Investors of record on Monday, September 21st will be issued a dividend of $0.05 per share. The ex-dividend date of this dividend is Monday, September 21st. This represents a $0.20 dividend on an annualized basis and a dividend yield of 0.3%. Bruker’s payout ratio is presently -28.57%.

Wall Street Analysts Forecast Growth

BRKR has been the subject of several recent research reports. Barclays increased their price target on Bruker from $53.00 to $60.00 and gave the company an “overweight” rating in a research report on Wednesday, June 24th. Leerink Partners upped their price objective on Bruker from $60.00 to $70.00 and gave the stock an “outperform” rating in a research note on Tuesday, July 7th. JPMorgan Chase & Co. increased their price objective on Bruker from $55.00 to $65.00 and gave the company an “overweight” rating in a report on Monday, June 8th. Weiss Ratings reissued a “sell (d+)” rating on shares of Bruker in a research note on Monday, August 31st. Finally, UBS Group set a $60.00 target price on shares of Bruker in a research note on Wednesday, June 24th. One equities research analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating, five have assigned a Hold rating and two have assigned a Sell rating to the stock. Based on data from MarketBeat, Bruker presently has a consensus rating of “Hold” and an average price target of $56.64.

Bruker Profile

Bruker Corporation, founded in 1960 by physicist Günther Laukien and headquartered in Billerica, Massachusetts, is a leading developer and manufacturer of high-performance scientific instruments and analytical solutions. The company designs systems that enable molecular and materials research across academic, governmental, and industrial laboratories.

Bruker’s product portfolio encompasses nuclear magnetic resonance (NMR) spectrometers for molecular structure and dynamics studies, mass spectrometry platforms for proteomics and metabolomics, X-ray diffraction and scattering instruments for crystallography and materials characterization, atomic force and scanning probe microscopes for nanoscale surface analysis, as well as preclinical imaging systems such as micro-CT and MRI scanners.

In addition to hardware, Bruker provides software suites, applications support, training services, and long-term maintenance agreements to ensure optimal instrument performance.